Capricor Therapeutics, Inc. is a pioneering biotechnology company headquartered in Beverly Hills, California, dedicated to the advancement of cell- and exosome-based therapies targeting a range of serious diseases. The firm’s innovative approach to regenerative medicine leverages proprietary technologies to develop solutions that address significant unmet medical needs within various therapeutic areas. With a robust R&D pipeline and a strong commitment to scientific excellence, Capricor is well-positioned to enhance patient outcomes and establish strategic partnerships in the biopharmaceutical landscape, aiming to drive transformative advancements in healthcare. Show more
Location: 10865 ROAD TO THE CURE, SAN DIEGO, CA, UNITED STATES, 92121, San Diego, CA, 92121, USA | Website: https://www.capricor.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
1.253B
52 Wk Range
$4.30 - $40.37
Previous Close
$23.03
Open
$23.36
Volume
1,131,185
Day Range
$23.23 - $25.21
Enterprise Value
1.249B
Cash
19.51M
Avg Qtr Burn
-19.69M
Insider Ownership
16.80%
Institutional Own.
39.19%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Deramiocel (CAP-1002) Details Duchenne muscular dystrophy (DMD) | BLA Resubmission | |
StealthX vaccine Details SARS-CoV-2 | Phase 1 Data readout | |
CAP-1002 Details COVID-19 | Failed Discontinued |
